Trade RCUS stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Arcus Biosciences, Inc. (RCUS) is trading at US$25.97, up 2.89% today as of Sep 21, 10:47 EDT. The company has a market capitalisation of US$3.86B. Over the past 52 weeks, RCUS has traded between US$12.15 and US$31.74. On Syfe you can trade RCUS with $0 commission and add it to your watchlist.
| Previous close | US$25.24 |
|---|---|
| Market cap | US$3.86B |
| 52-week range | US$12.15 – US$31.74 |
| Volume | 2.9M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Arcus Biosciences, Inc.
Arcus Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of immunotherapies. It competes in the segments of the pharmaceutical, biotechnology, and other related markets that develop immunotherapies for the treatment of cancer. The company was founded by Terry J. Rosen and Juan Carlos Jaen in 2015 and is headquartered in Hayward, CA.
Year: 2018
Arcus Biosciences' Casdatifan Therapy Could be Launched in 2028, Morgan Stanley Says
Aug 10, 4:01 PM · MT Newswires
Morgan Stanley Adjusts Price Target on Arcus Biosciences to $23 From $22, Maintains Equalweight Rating
Aug 10, 9:41 AM · MT Newswires
Wedbush Adjusts Price Target on Arcus Biosciences to $43 From $41, Maintains Outperform Rating
Aug 6, 1:01 PM · MT Newswires
-- Earnings Flash (RCUS) Arcus Biosciences, Inc. Reports Q2 Revenue $41.0M
Aug 5, 8:42 PM · MT Newswires
Arcus Biosciences, Inc. (RCUS) stock is trading at US$25.97, +2.89% from the previous close of US$25.24.
The market cap for Arcus Biosciences, Inc. (RCUS) stock is approximately US$3.86B.
The 52-week high for Arcus Biosciences, Inc. (RCUS) stock is US$31.74.
The 52-week low for Arcus Biosciences, Inc. (RCUS) stock is US$12.15.
Arcus Biosciences, Inc. (RCUS) does not currently pay a dividend.
Stay on top of RCUS
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
